250+ investors that invest in your industry and stage
Marketplace
Gaming
Community
Proptech
Biotech
Impact
Health Care
FinTech
Energy
Artificial intelligence
Google
Consumer
Climate
Hardware
EdTech
Sustainability
Real Estate
Venture Capital
Digital Media
Music
Finance
Android
Franchise
Construction
Enterprise Software
Sports
Manufacturing
Retail
Email
Internet
Social Media
Social Network
Local
Web3
Wellness
Medical
Art
Legal
Mobile
Video Games
eSports
Biotechnology
Platforms
Cannabis
Fitness
Travel
Recruiting
Mobile Advertising
Hospitality
Automotive
Crowdfunding
Social
Medical Device
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
Publishing
LGBT
Beauty
Education
B2B
Payments
Organic Food
Infrastructure
Food and Beverage
Fashion
Oil and Gas
Financial Services
Photography
Theatre
Film
Life Science
Clean Energy
Big Data
Non Profit
Renewable Energy
SaaS
Restaurants
Sporting Goods
Celebrity
Software
Social Impact
Cryptocurrency
Blockchain
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
United Kingdom
United States
Germany
India
Australia
Canada
New Zealand
South Korea
Ireland
Saudi Arabia
Brazil
Armenia
Qatar
Asia
Sri Lanka
Europe
Spain
South Africa
Vietnam
Japan
Singapore
Middle East
LATAM
China
Belgium
Africa
Hungary
Oceania
Faroe Islands
Belarus
Bahrain
Gibraltar
Indonesia
France
Barbados
Greece
Liberia
Belize
Kuwait
Hong Kong
Philippines
Algeria
Ghana
Finland
Malaysia
Czech Republic
Estonia
Morocco
Croatia
Bermuda
Peru
Chile
Costa Rica
Nicaragua
Georgia
Ecuador
Bulgaria
Malta
Denmark
Mexico
Ethiopia
Egypt
Lithuania
Ukraine
Turkey
Serbia
Sierra Leone
Rwanda
Venezuela
Lebanon
Sweden
Senegal
Jersey
Myanmar
Tajikistan
Puerto Rico
Portugal
Mali
Liechtenstein
Uganda
Taiwan
Israel
Slovenia
Panama
Togo
Russian Federation
Tanzania
Zimbabwe
San Marino
Uruguay
Italy
Poland
El Salvador
Mauritius
Thailand
Tunisia
Norway
Zambia
Uzbekistan
Dominican Republic
Bahamas
United Arab Emirates
Jamaica
Namibia
Honduras
Azerbaijan
Iceland
Bolivia
Isle of Man
Mozambique
Luxembourg
Nigeria
Albania
Pakistan
Iraq
Grenada
Jordan
Romania
Argentina
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Austria
Cyprus
Oman
Latvia
Cameroon
Switzerland
Seychelles
Colombia
Guatemala
Marshall Islands
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Life Science Startup Investors in France in May 2026

A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.

Top 50 Life Science Startup Investors in France in May 2026

Investor Life Science France investments
Bpifrance 14
Kurma Partners 8
Seventure Partners 6
Omnes Capital 6
Sofinnova Partners 5
Paca Investissement 4
Idinvest Partners 4
AdBio partners 4
Galia Gestion 3
Karista 3
Boehringer Ingelheim Venture Fund 3
Blue Horizon Corporation 3
Advent Life Sciences 3
AQUITI Gestion 2
Point Nine 2
Angels Santé 2
IRDI SORIDEC Gestion 2
Polytechnique Ventures 2
Air Street Capital 2
Siparex Groupe 2
Lundbeckfonden Ventures 2
Heartcore Capital 2
JDRF T1D Fund 2
Sylvain Zimmer 2
Alexandria Venture Investments 2
Beyond Impact 2
Invus 2
Social Starts 2
Kinled Holding 2
XAnge 2
Thia Ventures 2
Eutopia VC 2
WiSEED 2
Horizons Ventures 2
Sofimac Investment Managers 2
Partech 2
Andrew Nutter 2
Illumina Ventures 1
Bioam Gestion 1
Limburg Ventures 1
Eternam 1
AFI Ventures 1
Capitole Angels 1
CELESTE 1
Irwan Bello 1
Amundi Private Equity Funds 1
Inserm Transfert Initiative 1
ADI Nouvelle-Aquitaine 1
Calao Finance 1
ACT Venture Partners 1

Reach every investor

Get a list of investors who already back your industry, stage, and country. Emails & phones included.

Find investors — It's Free!
Investor list
Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Funding Round, Series A
  • France, United States, Switzerland

Portfolio highlights

  • Gamevestor — Be more than a player. Invest in expert-selected video game projects and earn a share of their commercial revenues.
  • IsentroniQ — Isentroniq solves the critical cryogenic power and space bottleneck in quantum computing. Our dense, near-heatless wiring solution unlocks 1000x more qubits.
  • SWEETECH — SWEETECH is a deeptech startup that specializes in the biosynthesizing of rare sugars (oligosaccharides) using a patented, eco-friendly fermentation platform. Born from a passion for biotechnology and sustainable chemistry.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Series A, Seed, Series B
  • France, Switzerland, Spain

Portfolio highlights

  • Laigo Bio — Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Series A, Funding Round, Series B
  • France, United States, Germany

Portfolio highlights

  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Hepster — hepster, die Onlineversicherung, flexibel, sicher und immer 100% digital.
  • BAOUW / Outdoor Organic Nutrition — A raw, healthy, and natural diet made up of energy gels, energy bars, and energy fruit purees.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States

Portfolio highlights

  • Caracol — Lead the future of manufacturing thanks to Caracol's 3D printing technologies. Discover our solutions for industrial, Large Format Additive Manufacturing.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
  • Amakem — Easy, affordable options for you to obtain the domain you want. Safe and secure shopping.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom

Portfolio highlights

  • NodThera — NodThera is a biotechnology company treating chronic diseases by targeting inflammation at its source.
  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Show all investments...

Paca Investissement
VC Fund · Paris, Ile-de-France, France

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Show more...

Investment focus

  • Software, Internet, Manufacturing
  • Seed, Funding Round, Series A
  • France

Portfolio highlights

  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Series B, Series A, Funding Round
  • France, United States, Spain

Portfolio highlights

  • wefox — wefox is a digital insurance company aiming to make people safe and prevent risk by reinventing insurance at scale through technology. Its focus is selling insurance via intermediaries and not via direct channels. Through analytics, wefox achieves better loss ratios than the market. Technology allows wefox to have >90%straight-through-processing and a central product factory that ships product innovations internationally much quicker and more cost-effective than the competition.Wefox has built up a network of thousands of digitally enabled advisors across Europe which increases customer satisfaction, reduces customer acquisition costs, increases cross-selling, and decreases churn.Wefox was founded in 2015 and is based in Berlin, Germany.
  • Secret Escapes — Luxury travel at low prices with Secret Escapes. Secret Escapes is an exclusive members only travel club offering our members huge discounts and great deals on hand-picked luxury hotels and holidays
  • Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Funding Round
  • France, Spain, Belgium

Portfolio highlights

  • Cephagenix — Cephagenix focuses on identifying and developing new, effective migraine therapies.
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Software, Manufacturing, Biotechnology
  • Funding Round, Series A, Seed
  • France, United States

Portfolio highlights

  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Seed, Series A, Series B
  • France, United States, Finland

Portfolio highlights

  • CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
  • Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
  • Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium

Portfolio highlights

  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
Show all investments...

Blue Horizon Corporation
VC Fund · Zürich, Zurich, Switzerland

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Show more...

Investment focus

  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Germany

Portfolio highlights

  • WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
  • foodforecast — AI supported solution to reduce food waste.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 1 investment in the past 12 months

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • United States, United Kingdom, France

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Relief Cardiovascular — Relief Cardiovascular is an inQB8 medical technologies portfolio company developing a revolutionary smart implant to decongest heart failure patients.
Show all investments...

AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Show more...

Investment focus

  • Biotechnology, Software, Manufacturing
  • Funding Round, Series A, Seed
  • France, United States

Portfolio highlights

  • Speeral — Speeral est la plateforme SaaS qui automatise le cycle complet de vente sur les marketplaces C2C et vous permet de tirer profit du canal.
  • Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
  • Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
Show all investments...

Point Nine
VC Fund · Berlin, Berlin, Germany

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

Show more...

Investment focus

  • Software, SaaS, Internet
  • Seed, Series A, Series B
  • Germany, United States, France

Portfolio highlights

  • cargo.one — The cargo.one booking platform gives you access to real-time prices and available capacities of multiple airlines. Directly book online within seconds, 24/7.
  • Omnea — The all-in-one procurement platform. Request purchases, automate approvals, and streamline your procurement process in one centralised solution.
  • Delivery Hero — Delivery Hero is the world's leading local delivery company. We are on a mission to deliver an amazing experience - fast, easy, and to your door.
Show all investments...

Angels Santé
VC Fund · Puteaux, Ile-de-France, France

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Seed, Funding Round, Angel
  • France, India, United States

Portfolio highlights

  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Odimma — Empowering personalized immunotherapy to treat cancer
  • AUSTRAL Dx — Austral Dx develops contactless AI technology for rapid cardiopulmonary diagnostics, helping clinicians identify life-threatening conditions faster in emergency care.
Show all investments...

IRDI SORIDEC Gestion
VC Fund · Toulouse, Midi-Pyrenees, France

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Show more...

Investment focus

  • Software, Biotechnology, Medical
  • Seed, Series A, Funding Round
  • France, Brazil, Singapore

Portfolio highlights

  • bYoRNA — bYoRNA is a French biotechnology company specializing in the cost-efficient, scalable bioproduction of high-quality therapeutic messenger RNA (mRNA) using engineered eukaryotic cells, particularly recombinant yeast. Their disruptive platform enables the production of long, humanized mRNA with lower immunogenicity and higher integrity compared totraditional in vitro enzymatic synthesis. This technology aims to mass produce mRNA for gene therapies, cancer vaccines, and infectious disease vaccines at a fraction of current costs, making mRNA therapeutics more accessible globally.
  • Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
  • Greenphage — Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions tosupport its phage therapy efforts.
Show all investments...

Polytechnique Ventures
VC Fund · Paris, Ile-de-France, France

Polytechnique Ventures support entrepreneurs from the School's ecosystem.

Show more...

Investment focus

  • Biotechnology, Energy, Robotics
  • Seed, Series A, Funding Round
  • France, United Kingdom, United States

Portfolio highlights

  • bYoRNA — bYoRNA is a French biotechnology company specializing in the cost-efficient, scalable bioproduction of high-quality therapeutic messenger RNA (mRNA) using engineered eukaryotic cells, particularly recombinant yeast. Their disruptive platform enables the production of long, humanized mRNA with lower immunogenicity and higher integrity compared totraditional in vitro enzymatic synthesis. This technology aims to mass produce mRNA for gene therapies, cancer vaccines, and infectious disease vaccines at a fraction of current costs, making mRNA therapeutics more accessible globally.
  • Gobano Robotics — Gobano Robotics develops AI-driven robots capable of automating complex, dexterous tasks. Their solutions include soft manipulation, bin picking, packing and unpacking, and precise assembly operations. The robots learn from real-world experiences, improving performance to handle new situations with human-like decision-making. They are designed toreplace manual labor with automated processes.
  • One Biosciences — One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases. Magali Richard, David Schilansky, and Céline Vallot co-founded the company in Paris, Ile-de-France, France.
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Artificial Intelligence, Software, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, France

Portfolio highlights

  • Clove — Building the financial institution of the future.
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Show all investments...

Siparex Groupe
VC Fund · Paris, Ile-de-France, France

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Show more...

Investment focus

  • Manufacturing, Software, Information Technology
  • Private Equity, Funding Round, Seed
  • France, United States, Italy

Portfolio highlights

  • E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
  • NeoPhotonics — NeoPhotonics design and manufacture advanced hybrid photonic integrated optoelectronic devices for ultra-fast communications networks, including optical components
  • Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
Show all investments...

Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in the past 12 months

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Denmark, United Kingdom

Portfolio highlights

  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • Notify Therapeutics — Notify Therapeutics develops therapies for the treatment of infertility. By targeting the early and hormone-independent phase of egg maturation, the company aims at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. It utilizes drug-inducing factors that regulate the intracellular AKTpathway and target the early and hormone-independent phase of egg maturation for the treatment.
Show all investments...

Heartcore Capital
VC Fund · Copenhagen, Hovedstaden, Denmark

Heartcore Capital invests in companies re-enchanting the world through technology.

Show more...

Investment focus

  • Software, FinTech, Artificial Intelligence
  • Seed, Series A, Series B
  • Denmark, United States, Germany

Portfolio highlights

  • Voyfai — A European group of independent freight forwarders, operating autonomously at local level while sharing scale, technology, and partnerships.
  • FINN — At finn our mission is to make mobility fun and sustainable: We help everyone who loves driving their own car but refuses the struggle, commitment and intransparent costs associated with car ownership. We achieve this by offering all-inclusive, immediately available, monthly car-subscriptions. Best thing, yet: While you drive we plant trees asevery journey is CO2 compensated.
  • Kenbi — Lovable Generated Project
Show all investments...

JDRF T1D Fund
VC Fund · Boston, Massachusetts, United States

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Funding Round
  • United States, Canada, France

Portfolio highlights

  • vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
  • Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
  • Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Show all investments...

Sylvain Zimmer
Angel · Paris, Ile-de-France, France

Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.

Show more...

Investment focus

  • Software, SaaS, Food and Beverage
  • Seed, Pre-Seed, Angel
  • France, United States, United Kingdom

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Canada, France

Portfolio highlights

  • Tr1x — Tr1x develops cellular therapies intended for the treatment of autoimmune disorders.
  • Proxima — Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes. It focuses on creating proximity-modulating therapeutics that direct protein interactions for potential use in conditions such as autoimmune disorders and cancer, expanding the range of targets that traditional drugs cannot easily reach.Proxima Bio combines structural biology, data generation, and machine learning to identify actionable protein-protein interfaces and support the discovery of new therapeutic modalities. The company works with pharmaceutical partners to apply its platform in research collaborations and advance drug discovery pipelines. Proxima Bio’s platform integrates multiple technologies to support the design and discovery of novel proximity-based treatment approaches.
  • NILO Therapeutics — A neuronal circuit regulates the immune system. We're targeting it to treat autoimmune and inflammatory diseases.
Show all investments...

Beyond Impact
VC Fund · Minneapolis, Minnesota, United States

Beyond Impact is your trusted Managed Service Provider (MSP), delivering tailored IT solutions like managed IT services, cybersecurity, cloud computing, IT help desk support, and data backup. Our expert team aligns your IT with business goals, providing proactive monitoring and network security. Contact us today to streamline your IT operations for a secure, agile, and future-ready business. Beyond Impact: Empowering your IT success.

Show more...

Investment focus

  • Food and Beverage, News, Seafood
  • Seed, Series A, Pre-Seed
  • France, Canada, Singapore

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
  • SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.
Show all investments...

Invus
VC Fund · New York, New York, United States

Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series B, Series C, Series A
  • United States, France, China

Portfolio highlights

  • Zero Motorcycles — Manufacturer of 100% electric motorcycles for the street and dirt.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • Lexicon Pharmaceuticals — Lexicon Pharmaceuticals, Inc. (formerly Lexicon Genetic) a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The company's drug candidates include LX1031, which has completed Phase II clinical trialsfor the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolution's Chemetics platform chemistry technology.
Show all investments...

Social Starts
VC Fund · San Francisco, California, United States

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Show more...

Investment focus

  • Software, Health Care, Artificial Intelligence
  • Seed, Series A, Funding Round
  • United States, Germany, United Kingdom

Portfolio highlights

  • Dyad Medical — Dyad Medical develops software that automatically analyzes the content of cardiac and cardiovascular images. Its software applications support both treatment decision making in the clinic and analysis in research, enabling researchers to optimize observations and conclusions. It was founded in 2018 and headquartered in Boston, Massachusetts.
  • Original Stitch — PLATINUMTOTO hadir sebagai situs togel macau di Indonesia yang sangat populer di kalangan togelers platinumtoto dengan jackpot 4D setiap hari nya
  • Bark Technologies — Learn how Bark's parental controls can help you protect your kids online and in real life with monitoring, screen time controls, and more.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Switzerland

Portfolio highlights

  • Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
  • OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
  • Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Series A, Seed, Series B
  • France, Germany, Belgium

Portfolio highlights

  • HABX — habx provides real estate developers with a digital solution enabling the personalization of new housing units
  • Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
  • Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Biotechnology, Health Care, Food and Beverage
  • Series A, Seed, Series B
  • United States, France, Denmark

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Protealis — Sustainable plant proteins for Europe​
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Show all investments...

Eutopia VC
VC Fund · Paris, Ile-de-France, France

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

Show more...

Investment focus

  • Retail, E-Commerce, Food and Beverage
  • Seed, Series A, Funding Round
  • France, Belgium, Denmark

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
  • SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Software, Manufacturing, Biotechnology
  • Seed, Funding Round, Equity Crowdfunding
  • France

Portfolio highlights

  • Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
  • Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada

Portfolio highlights

  • Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
  • Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
  • Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Show all investments...

Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Biotechnology, Health Care, Manufacturing
  • Funding Round, Seed, Series A
  • France, Italy, Austria

Portfolio highlights

  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

Partech
VC Fund · Paris, Ile-de-France, France

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Show more...

Investment focus

  • Software, E-Commerce, SaaS
  • Series A, Seed, Series B
  • United States, France, Germany

Portfolio highlights

  • Djamo — Djamo is a Provider of financial applications to allow customers to use their cards with zero fees in a wide range of services.
  • Yampa — Discover yampa's autonomous AI agents and revolutionize your customer experience. Elevate your service with the most advanced AI technology.
  • HostnFly — HostnFly develops algorithms to optimize the income from rented apartments on Airbnb. The company also offer Parisians to take care of their apartment rental by guaranteeing an income.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Software, SaaS, FinTech
  • Seed, Pre-Seed, Funding Round
  • France, United Kingdom, United States

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants
  • Jump — Jump takes the hassle out of being a freelancer. We accompany hundreds of freelancers in their daily lives by securing their adventure. Relax, we take care of everything.
  • Core Biogenesis — Biodesigning the Future of Regenerative Medicine & Skincare
Show all investments...

Illumina Ventures
VC Fund · Foster City, California, United States

We invest in companies that are advancing the field of genomics and pioneering new applications in healthcare, agriculture, environmental science, and personal

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, United Kingdom, France

Portfolio highlights

  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • DeepSeq.AI — Explore DeepSeq.AI - revolutionizing protein screening and drug design with cutting-edge AI. We empower researchers to accelerate discoveries and transform healthcare.
  • Alamar Biosciences — Alamar Biosciences is a proteomics company redefining the limits of Protein Biomarker Detection with unrivaled precision. Learn more about what we offer here.
Show all investments...

Bioam Gestion
VC Fund · Paris, Ile-de-France, France

Bioam Gestion is a venture capital firm that offers a range of credit, insurance, and tax exemption services to its clients.Credit consists of credit repurchase, real estate credit, and consumer credit. Insurance consists of mutual health, life insurance, animal insurance, and prevention. Tax exemption consists of penal law and LMNP.BioamGestion was founded in 2000 and is based in Paris.

Show more...

Investment focus

  • Biotechnology, Therapeutics, Health Care
  • Series B, Seed, Series A
  • France

Portfolio highlights

  • TxCell — TxCell, a spin off of Inserm (France's National Institute for Health and Medical Research) located in the technology park of Sophia Antipolis, near Nice in southern France, is developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technologyplatform based on the properties of Type 1 regulatory T lymphocytes (Tr1 cells). The company has completed enrollment of a PhI/II study in refractory Crohn's disease patients and has reported first positive results. The company plans to initiate a PhIIb study in the same patient population and bring a second product candidate into a PhI/II study in refractory rheumatoid arthritis patients.
  • Cytheris — Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such aschemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).
  • SuperSonic Imagine — SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom.
Show all investments...

Limburg Ventures
VC Fund · Maastricht, Limburg, The Netherlands

Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.

Show more...

Investment focus

  • Biotechnology, Health Care, Life Science
  • Funding Round, Series A, Series B
  • The Netherlands, France, Belgium

Portfolio highlights

  • Q Chip — IDN Poker merupakan situs judi poker online terpercaya yang menyediakan apk idn play resmi Indonesia. Daftar idn poker 88 mania sekarang dan raih kemenangannya.
  • FABPulous — FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, HealthInnovations, Limburg Ventures and NV Industriebank LIOF.The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
  • ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.
Show all investments...

Eternam
VC Fund · Paris, Ile-de-France, France

Eternam engages in business throughout the commercial real estate value chain, including investments in residential plots, club deals, SCPI allocation guidance, and real estate investment funds. They are specialists in club negotiations, capital invested in real estate, and the structuring of company real estate operations. Along with propertyadvisory services, they provide real estate investment and property management services.

Show more...

Investment focus

  • Health Care, Life Science, Clinical Trials
  • Series A
  • France

Portfolio highlights

  • DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
Show all investments...

AFI Ventures
VC Fund · Paris, Ile-de-France, France · 3 investments in the past 12 months

Alliance For Impact (AFI) is a category-defining structure for impact companies combining equity-free acceleration with first-ticket seed funding.

Show more...

Investment focus

  • Environmental Consulting, GreenTech, Health Care
  • Seed, Pre-Seed, Series A
  • France, Belgium, Germany

Portfolio highlights

  • Moonwatt — Moonwatt solves problems of the energy transition through innovative energy products hardware and software.
  • Tilt Energy — We are passionate engineers, PhD, business grads on a mission to help the energy transition using our skills: software and AI ! As we need to produce and consume energy in a more responsible, efficient and low-carbon way, our solution enables decentralized energy consumers to better integrate into the grid. We are building an innovative platformthat empowers the widespread adoption of renewable energies and everyone to take charge of their energy consumption. If energy is a topic at heart and you like challenge then join us !
  • Nova Carbon — High-performance sustainable carbon fiber composites
Show all investments...

Capitole Angels
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investment in the past 12 months

Capitole Angels is to create this association was born from the experience of many of its founders in the field of start-ups including the following observations. Need a structure enabling them to meet investors / promoters of the project. Plethora of potential investors hampered by the lack of an open structure. A region rich in technology,its universities, laboratories and therefore the bearer of innovation.

Show more...

Investment focus

  • Information Technology, Software, 3D Technology
  • Seed, Angel, Funding Round
  • France

Portfolio highlights

  • Hoope — Hoope offers crunchy mueslis, spreads, and biscuits rich in nutrients, all organic, without palm oil, additives.
  • Deepbloo — DeepBloo is a Sales and Market Intelligence platform. We provide : + 5.8 millions tenders and market information Worldwide and + 300 000 tenders in France
  • Sensivic — Designed and manufactured in France, SENSIVIC smart audio detection systems add meaning to your security. Our solutions automatically detect and alert you in real time as soon as an abnormal sound or suspicious noise occurs.
Show all investments...

CELESTE
VC Fund · Champs-sur-marne, Ile-de-France, France

CELESTE operates as an Internet provider for different companies. The company offers a range of solutions which covers Internet access, MPLS interconnection and fiber optics, IP telephony or ecological data center hosting. CELESTE was founded in 2001 and is headquartered in Champs-sur-marne, Ile-de-France.

Show more...

Investment focus

  • Health Care, Life Science, Clinical Trials
  • Series A
  • France

Portfolio highlights

  • DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
Show all investments...

Irwan Bello
Angel · San Francisco, California, United States · 3 investments in the past 12 months

Irwan Bello is an individual investor.

Show more...

Investment focus

  • Information Technology, Internet, Life Science
  • Seed, Pre-Seed
  • France, United States

Portfolio highlights

  • Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
  • Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
  • Twin — Twin Labs, offer an automated tool for repetitive operations, such as onboarding new staff to all internal systems.
Show all investments...

Amundi Private Equity Funds
VC Fund · Paris, Ile-de-France, France

Amundi Private Equity Funds, an Amundi asset management subsidiary, specialises in private equity and unlisted infrastructure investments. Combining a wealth of expertise in all aspects of asset management built up over more than 10 years, Amundi provides both institutional and individual investors with a wide spectrum of investmentopportunities, ranging from direct fund investments in unlisted French and foreign companies to dedicated mandates and funds-of-funds for multi-management private equity and infrastructure investments. With more than 60 professionals based in Paris, Bucharest, Cairo, Casablanca, Tunis and Warsaw, Amundi Private Equity Funds assists companies at all stages of their development, the key objective being to offer fund subscribers yields in line with the best in the industry. At 31 December 2009, French and international subscribers had committed more than €3.7 billion to Amundi Private Equity Funds, making it a leading private equity player. The company owes its solid foundations to its positioning as part of a leading third-party asset management group of companies and to its membership of two international banking groups.

Show more...

Investment focus

  • Software, E-Commerce, Biotechnology
  • Funding Round, Private Equity, Series A
  • France, India, Hungary

Portfolio highlights

  • Vivalto Vie — Vivalto Vie is a privately held company that operates retirement homes in the Poitou-Charentes and Pays de la Loire regions.
  • Airtel — Bharti Airtel Limited, commonly known as Airtel, is an Indian multinational telecommunications services company headquartered in New Delhi, India. It operates in 20 countries across South Asia, Africa, and the Channel Islands. Airtel has a GSM network in all countries in which it operates, providing 2G, 3G and 4G services depending upon the countryof operation.Airtel is the largest provider of mobile telephony and second largest provider of fixed telephony in India, and is also a provider of broadband and subscription television services. It offers its telecom services under the "airtel" brand, and is headed by Sunil Bharti Mittal. Bharti Airtel is the first Indian telecom service provider to achieve Cisco Gold certification. It also acts as a carrier for national and international long distance communication services. The company has a submarine cable landing station at Chennai, which connects the submarine cable connecting Chennai and Singapore.
  • Les Opticiens Mobiles — Les Opticiens Mobiles is the first national network of opticians trained to intervene everywhere : at home, at work or in nursing homes or residences for elderly, both for working people and for fragile, isolated people.Covering the whole territory, the health professionals come to visit you with all the equipment needed. Based on an ethic chart,they offer services and products tailored to all : all types of glasses (eyeglasses, sunglasses, safety googles, contact lenses, hearing protection) with fixed prices, reimbursed by social welfare.
Show all investments...

Inserm Transfert Initiative
VC Fund · Paris, Ile-de-France, France

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Series A, Series B, Seed
  • France, Switzerland, United States

Portfolio highlights

  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — We Are Ironwood
  • Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
Show all investments...

ADI Nouvelle-Aquitaine
VC Fund · Pessac, Aquitaine, France

ADI Nouvelle-Aquitaine is a non-profit organization that renders fundraising, strategy, innovation management, and support services.

Show more...

Investment focus

  • Life Science, Biotechnology, Waste Management
  • Seed
  • France

Portfolio highlights

  • Dionymer — dionymer creates endless opportunities for a multitude of industries. Replacing petrochemical polymers with a circular and biodegradable alternative.
  • Midipile Mobility — Midipile Mobility is a B2B subscription-based turnkey service for logistics professionals. They target middle mile and last mile deliveries.Their service is built on a new type of vehicle: 4 wheels, closed body, solar, 45 km/h (28 mph). It includes fleet management tools (SaaS), insurance, maintenance and assistance. Midipile is a low-carbonalternative to delivery trucks independent from the grid thanks to free solar energy and battery swapping solution.Their services offers the guarantee of better profitability combined with a unique user experience and a controlled and quantified carbon footprint.
Show all investments...

Calao Finance
VC Fund · Paris, Ile-de-France, France · 2 investments in the past 12 months

CALAO Finance is an independent private equity company, specialized in financing European SME.

Show more...

Investment focus

  • Information Technology, Software, Big Data
  • Funding Round, Series A, Series B
  • France, United States

Portfolio highlights

  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
  • Kalray — DPU processors, accelerator cards, software-defined storage and data management solutions for high-performance, data-centric computing.
  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
Show all investments...

ACT Venture Partners
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in the past 12 months

Early stage deep tech investor

Show more...

Investment focus

  • Artificial Intelligence, Software, Manufacturing
  • Seed, Convertible Note, Series A
  • Turkey, United States, United Kingdom

Portfolio highlights

  • Nextmol — Nextmol is your partner to accelerate chemicals discovery. Reduce time-to-market and get key insights about the behavior of your chemical molecules!
  • Qubitrium — Explore innovative quantum solutions at Qubitrium. Elevate your journey with cutting-edge products, services, and trainings. Your quantum future...
  • Meddenovo Drug Design — Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes. Cyclic peptidesrepresent a groundbreaking class of compounds in pharmaceutical research. These molecules combine the best attributes of small molecules and large biologics, offering exceptional binding affinities, stability, and specificity. At Meddenovo, we are leaders in harnessing the potential of cyclic peptides, developing tailored solutions that push the boundaries of traditional drug discovery. Beyond small organic molecules, our expertise extends to peptide-based medicines and metal chelators, giving us a competitive edge in novel drug research and development. We excel in creating unique chemical spaces tailored to your needs and provide custom computational solutions for predicting drug resistance, elucidating biochemical reaction mechanisms, and conducting metal affinity analysis. At Meddenovo, we are dedicated to precision and reliability in drug discovery. Our approach reduces failure rates and improves outcomes, accelerating the journey from research to market. Our mission is to empower scientists worldwide with advanced, user-friendly AI tools, democratizing access to cutting-edge drug discovery technologies.
Show all investments...
Investors by industry
Investors by country
Investors in France by industry

Contact investors today

Find who invests in your industry, stage, and country in 5 minutes.

Find investors — It's Free!